Status:
COMPLETED
Stiripentol for the Treatment of Refractory Status Epilepticus
Lead Sponsor:
University Hospital Marburg
Conditions:
Status Epilepticus
Eligibility:
All Genders
18+ years
Brief Summary
The investigators retrospectively analyzed all patients who were admitted to the Department of Neurology at Marburg University Hospital between 2013 and 2023 with a diagnosis of (super)-refractory sta...
Detailed Description
The investigators retrospectively analyzed all patients who were admitted to the Department of Neurology, University Hospital Marburg, Germany, between 2013 and 2023 with a diagnosis of status epilept...
Eligibility Criteria
Inclusion
- adult patients who suffered from RSE or SRSE and received STP as add on therapy.
Exclusion
- children
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2024
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT06540378
Start Date
January 1 2013
End Date
May 1 2024
Last Update
August 6 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.